Liposomal methemoglobin as a potent antidote for hydrogen sulfide poisoning

Toxicol Appl Pharmacol. 2022 Sep 1:450:116159. doi: 10.1016/j.taap.2022.116159. Epub 2022 Jul 5.

Abstract

Hydrogen sulfide (H2S) induces acute and lethal toxicity at high concentrations. However, no specific antidotes for H2S poisoning have been approved. Liposomal methemoglobin (metHb@Lipo) was developed as an antidote for cyanide poisoning. As the toxic mechanism of H2S poisoning is the same as that of cyanide poisoning, metHb@Lipo could potentially be used as an antidote for H2S poisoning. In this study, we evaluated the antidotal efficacy of metHb@Lipo against H2S poisoning. Stopped-flow rapid-scan spectrophotometry clearly showed that metHb@Lipo scavenged H2S rapidly. Additionally, metHb@Lipo showed cytoprotective effects against H2S exposure in H9c2 cells by maintaining mitochondrial function. MetHb@Lipo treatment also improved the survival rate after H2S exposure in vivo, with the maintenance of cytochrome c oxidase activity and suppression of metabolic acidosis. Moreover, metHb@Lipo therapy maintained significant antidotal efficacy even after 1-year-storage at 4-37 °C. In conclusion, metHb@Lipo is a candidate antidote for H2S poisoning.

Keywords: Antidote; Detoxification; Hydrogen sulfide poisoning; Liposome; Methemoglobin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antidotes / pharmacology
  • Antidotes / therapeutic use
  • Cyanides
  • Humans
  • Hydrogen Sulfide* / metabolism
  • Methemoglobin / metabolism
  • Methemoglobin / pharmacology
  • Poisoning* / drug therapy

Substances

  • Antidotes
  • Cyanides
  • Methemoglobin
  • Hydrogen Sulfide